It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Hepatitis Delta virus (HDV) is a satellite of Hepatitis B virus with a single-stranded circular RNA genome. HDV RNA genome synthesis is carried out in infected cells by cellular RNA polymerases with the assistance of the small hepatitis delta antigen (S-HDAg). Here we show that S-HDAg binds the bromodomain (BRD) adjacent to zinc finger domain 2B (BAZ2B) protein, a regulatory subunit of BAZ2B-associated remodeling factor (BRF) ISWI chromatin remodeling complexes. shRNA-mediated silencing of BAZ2B or its inactivation with the BAZ2B BRD inhibitor GSK2801 impairs HDV replication in HDV-infected human hepatocytes. S-HDAg contains a short linear interacting motif (SLiM) KacXXR, similar to the one recognized by BAZ2B BRD in histone H3. We found that the integrity of the S-HDAg SLiM sequence is required for S-HDAg interaction with BAZ2B BRD and for HDV RNA replication. Our results suggest that S-HDAg uses a histone mimicry strategy to co-activate the RNA polymerase II-dependent synthesis of HDV RNA and sustain HDV replication.
Histone mimicry of viral components is a strategy to subvert host factors for virus replication. Here, the authors show that an acetylated histone-like motif of the small Hepatitis Delta Antigen (S-HDAg) interacts with the chromatin remodeler BAZ2B to recruit the DNA-dependent RNA polymerase II for HDV RNA replication.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 INSERM, U1052 UMR CNRS 5286, Cancer Research Center of Lyon (CRCL), Lyon, France (GRID:grid.462282.8) (ISNI:0000 0004 0384 0005)
2 Laboratoire de Virologie Moléculaire, INSERM U1134, Institut National de la Transfusion Sanguine, Paris, France (GRID:grid.418485.4) (ISNI:0000 0004 0644 1202)
3 Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Johann Wolfgang Goethe-University, Frankfurt am Main, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721)
4 INSERM, U1052 UMR CNRS 5286, Cancer Research Center of Lyon (CRCL), Lyon, France (GRID:grid.462282.8) (ISNI:0000 0004 0384 0005) ; Université de Genève, Département de Pathologie et Immunologie, Genève, Switzerland (GRID:grid.8591.5) (ISNI:0000 0001 2322 4988) ; Hôpital de la Croix Rousse, Hospices Civils de Lyon and Université Lyon I, Department of Infectious and Tropical Diseases, Lyon, France (GRID:grid.413306.3) (ISNI:0000 0004 4685 6736)
5 INSERM, U1052 UMR CNRS 5286, Cancer Research Center of Lyon (CRCL), Lyon, France (GRID:grid.462282.8) (ISNI:0000 0004 0384 0005) ; Sapienza University, Italian Institute of Technology (IIT) - Center for Life Nanoscience (CLNS), Rome, Italy (GRID:grid.7841.a)
6 INSERM, U1052 UMR CNRS 5286, Cancer Research Center of Lyon (CRCL), Lyon, France (GRID:grid.462282.8) (ISNI:0000 0004 0384 0005) ; Hôpital de la Croix Rousse, Hospices Civils de Lyon and Université Lyon I, Department of Hepatology, Lyon, France (GRID:grid.413306.3) (ISNI:0000 0004 4685 6736)
7 INSERM, U1052 UMR CNRS 5286, Cancer Research Center of Lyon (CRCL), Lyon, France (GRID:grid.462282.8) (ISNI:0000 0004 0384 0005) ; Sapienza University, Italian Institute of Technology (IIT) - Center for Life Nanoscience (CLNS), Rome, Italy (GRID:grid.7841.a) ; Hôpital de la Croix Rousse, Hospices Civils de Lyon and Université Lyon I, Department of Hepatology, Lyon, France (GRID:grid.413306.3) (ISNI:0000 0004 4685 6736)
8 INSERM, U1052 UMR CNRS 5286, Cancer Research Center of Lyon (CRCL), Lyon, France (GRID:grid.462282.8) (ISNI:0000 0004 0384 0005) ; Laboratoire de Microbiologie Clinique, Groupe des Hôpitaux Universitaires de Paris - Seine Saint Denis, UFR Santé Médecine, Biologie Humaine, Université Paris 13, Bobigny, France (GRID:grid.11318.3a) (ISNI:0000000121496883)